Fundraising FoxHydra Biosciences
Cambridge, US · Delaware LLC · 5 known investors
Find your way into Hydra Biosciences
Sign up to see every warm intro you have to Hydra Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Hydra Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
MM
Magdalene Moran, Ph.D.Executive
BC
Bert Chenard, Ph.D.Executive
RH
Russell HerndonExecutive
TB
Tom BurkeExecutive
Board
VM
Vincent MilesBoard director
JG
Jean GeorgeBoard directorManaging Partner at Lightstone Ventures
PG
Paul GoldenheimBoard director
RC
Robert CarpenterBoard director
SE
Steven E. HallBoard director
Investors · 5
Lightstone Ventureslisted by Lightstone VenturesPortola Valley
How we know: Lightstone Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Saints Capitallisted by Saints CapitalDenver
How we know: Saints Capital's portfolio page · Not right? Tell us
AbingworthreportedLondon · $15M – $30M
How we know: a partner's Signal profile · Not right? Tell us
Lilly Venturesreported
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$10.5M disclosed across 2 rounds · 2015–2019
▶$1raisedJun 2019 · 97 investors · BiotechnologyRule 506(b)
▶$1raisedJun 2019 · 97 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Russell HerndonExecutive Officer, Director
- Robert CarpenterDirector
- Vincent MilesDirector
- Steven HallDirector
- Paul GoldenheimDirector
- Offering amount
- $1
- Amount sold
- $1
- First sale
- May 2019
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$10.5MraisedMar 2015 · 7 investors · BiotechnologyRule 506(b)
▶$10.5MraisedMar 2015 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul GoldenheimDirector
- Magdalene Moran, Ph.D.Executive Officer
- Bert Chenard, Ph.D.Executive Officer
- Vincent MilesDirector
- Russell HerndonExecutive Officer, Director
- Robert CarpenterDirector
- Jean GeorgeDirector
- Tom BurkeExecutive Officer
- Steven E. HallDirector
- Offering amount
- $17.7M
- Amount sold
- $10.5M
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Hydra Biosciences went on to found or lead other companies.
Frequently asked questions
- Who are Hydra Biosciences's investors?
- Hydra Biosciences's investors include Lightstone Ventures, New Enterprise Associates (NEA), Saints Capital, Abingworth, Lilly Ventures.
- How much funding has Hydra Biosciences raised?
- Hydra Biosciences has disclosed $10.5M raised across 2 rounds.
- Where is Hydra Biosciences headquartered?
- Hydra Biosciences is headquartered in Cambridge, US.